The contribution of epigenetics to cancer immunotherapy L Villanueva, D Álvarez-Errico, M Esteller Trends in immunology 41 (8), 676-691, 2020 | 152 | 2020 |
Enhanced anti-tumor efficacy of checkpoint inhibitors in combination with the histone deacetylase inhibitor Belinostat in a murine hepatocellular carcinoma model D Llopiz, M Ruiz, L Villanueva, T Iglesias, L Silva, J Egea, JJ Lasarte, ... Cancer Immunology, Immunotherapy 68, 379-393, 2019 | 113 | 2019 |
Inhibition of FOXP3/NFAT interaction enhances T cell function after TCR stimulation T Lozano, L Villanueva, M Durántez, M Gorraiz, M Ruiz, V Belsue, ... The Journal of Immunology 195 (7), 3180-3189, 2015 | 55 | 2015 |
Eradication of large tumors expressing human papillomavirus E7 protein by therapeutic vaccination with E7 fused to the extra domain a from fibronectin C Mansilla, P Berraondo, M Durantez, M Martínez, N Casares, ... International Journal of Cancer 131 (3), 641-651, 2012 | 53 | 2012 |
IL-10 expression defines an immunosuppressive dendritic cell population induced by antitumor therapeutic vaccination D Llopiz, M Ruiz, S Infante, L Villanueva, L Silva, S Hervas-Stubbs, ... Oncotarget 8 (2), 2659, 2017 | 42 | 2017 |
Epigenetic profiling and response to CD19 chimeric antigen receptor T-cell therapy in B-cell malignancies CA Garcia-Prieto, L Villanueva, A Bueno-Costa, V Davalos, ... JNCI: Journal of the National Cancer Institute 114 (3), 436-445, 2022 | 32 | 2022 |
Combination of a TLR4 ligand and anaphylatoxin C5a for the induction of antigen-specific cytotoxic T cell responses F Rudilla, C Fayolle, N Casares, M Durantez, L Arribillaga, T Lozano, ... Vaccine 30 (18), 2848-2858, 2012 | 27 | 2012 |
Clinical testing of a dendritic cell targeted therapeutic vaccine in patients with chronic hepatitis C virus infection A Zabaleta, D D'avola, I Echeverria, D Llopiz, L Silva, L Villanueva, ... Molecular therapy Methods & clinical development 2, 2015 | 23 | 2015 |
A fusion protein between streptavidin and the endogenous TLR4 ligand EDA targets biotinylated antigens to dendritic cells and induces T cell responses in vivo L Arribillaga, M Durantez, T Lozano, F Rudilla, F Rehberger, N Casares, ... BioMed research international 2013, 2013 | 20 | 2013 |
Cold-inducible RNA binding protein as a vaccination platform to enhance immunotherapeutic responses against hepatocellular carcinoma L Silva, J Egea, L Villanueva, M Ruiz, D Llopiz, D Reparaz, B Aparicio, ... Cancers 12 (11), 3397, 2020 | 18 | 2020 |
Addition of immune checkpoint inhibitors to chemotherapy versus chemotherapy alone in first-line metastatic triple-negative breast cancer: A systematic review and meta-analysis G Villacampa, P Tolosa, F Salvador, R Sánchez-Bayona, L Villanueva, ... Cancer Treatment Reviews 104, 102352, 2022 | 17 | 2022 |
The Toll like receptor 4 ligand cold-inducible RNA-binding protein as vaccination platform against cancer L Villanueva, L Silva, D Llopiz, M Ruiz, T Iglesias, T Lozano, N Casares, ... Oncoimmunology 7 (4), e1409321, 2018 | 17 | 2018 |
Oncolytic viruses: A new immunotherapeutic approach for breast cancer treatment? JM Cejalvo, C Falato, L Villanueva, P Tolosa, X González, M Pascal, ... Cancer Treatment Reviews 106, 102392, 2022 | 12 | 2022 |
Bivalent therapeutic vaccine against HPV16/18 genotypes consisting of a fusion protein between the extra domain A from human fibronectin and HPV16/18 E7 viral antigens L Arribillaga, I Echeverria, V Belsue, T Gomez, T Lozano, N Casares, ... Journal for immunotherapy of cancer 8 (1), 2020 | 10 | 2020 |
DNA methylation-associated dysregulation of transfer RNA expression in human cancer M Rosselló-Tortella, A Bueno-Costa, L Martínez-Verbo, L Villanueva, ... Molecular Cancer 21 (1), 48, 2022 | 9 | 2022 |
Gene expression analysis during acute hepatitis C virus infection associates dendritic cell activation with viral clearance A Zabaleta, JI Riezu‐Boj, E Larrea, L Villanueva, JJ Lasarte, E Guruceaga, ... Journal of medical virology 88 (5), 843-851, 2016 | 3 | 2016 |
The HDAC inhibitor belinostat enhances the anti-tumor efficacy of immune checkpoint inhibitors in a murine hepatocellular carcinoma model D Llopiz, M Ruiz, L Villanueva, T Iglesias, JJ Lasarte, P Pivette, ... Journal of Hepatology 68, S677, 2018 | 2 | 2018 |
Comorbilidad del trastorno hipercinético en la práctica clínica P RodrigueZ-Ramos, R García-Pérez, FS Picazo, P Ortega, C Carrascosa, ... Revista de Psiquiatría Infanto-Juvenil, 226-232, 1997 | 1 | 1997 |
Abstract P22: PVR (CD155) epigenetic status mediates adoptive cell therapy and anti-TIGIT response in Multiple Myeloma L Martinez-Verbo, L Villanueva, P Llinàs-Arias, CA García-Prieto, ... Blood Cancer Discovery 5 (2_Supplement), P22-P22, 2024 | | 2024 |
CD155 on Multiple Myeloma Cells Is Epigenetically Regulated, Reduce Patients Survival and Compromises the Action of Novel Immunotherapies L Martinez-Verbo, L Villanueva, P Llinàs-Arias, CA García-Prieto, ... Blood 142, 6567, 2023 | | 2023 |